BACKGROUND The Amplatzer Amulet (St. Jude Medical, Minneapolis, MN, USA) is a second gen-eration Amplatzer device for left atrial appendage (LAA) occlusion (LAAO) for stroke prophylaxis in patients with atrial fibrillation. This research sought to assess the clinical performance of the Amplatzer Amulet device and in follow up for 12 months. METHODS In this single-center registry patients with...

Introduction: Diagnosis and treatment of ventricular septal defect (VSD) during infancy is great importance in improving the infant’s health. Patent ductus arteriosus (PDA) coarctation aorta are most common disorders associated with VSD. needs to be closed using surgical or non-surgical procedures. This article aims present a case repairing by stenting an infant VSD due placement large Amplatze...

Percutaneous transcatheter atrial septal defect (ASD) closure is a widely used technique that has replaced open-heart surgical closure in many centers. The most common implant is the Amplatzer septal occluder which seems to be a highly effective and safe device. However, there are reports of complications associated with its implantation. We report a 9-year-old boy who presented with complete a...

Ventriküler septal defektler transkateter tedavide kapatılması gereken bir defekt olarak görülmektedir. Son yıllarda yeni cihazların bulunması ile birçok merkezde ventriküler septal defektlerin perkütan kapatılması cesaretlendiren sonuçlarla uygulanmaktadır. Amplatzer oklüder sistemlerin son yıllarda kullanılmaya başlaması ile birlikte implantasyon sayılarında artma olmuştur. Bunun yanısıra, mü...

Transcatheter closure of patent ductus arteriosus with the Amplatzer duct occluder shows excellent results. However, there is a risk of device embolization after deployment. We report the case of a 33-year-old man in whom an embolized Amplatzer device was retrieved from the right pulmonary artery by a percutaneous method. We also review this uncommon severe complication and offer technical tips...

In selected patients, transcatheter closure of atrial septal defects with the AMPLATZER Septal Occluder has yielded excellent results. However, there is a slight risk of device embolization after deployment. We report the case of a 26-year-old woman in whom an embolized AMPLATZER device was retrieved percutaneously from the right pulmonary artery. We also discuss important technical principles ...

The association of a right aortic arch with an ipsilateral patent ductus arteriosus is rare, especially when there are no other intracardiac anomalies. We report three female patients aged 26, 35 and 9 years with this combination in whom previous attempts at surgical closure by thoracotomy and sternotomy were unsuccessful and who subsequently underwent successful percutaneous closure of the def...

OBJECTIVE Percutaneous transcatheter occlusion has benefited thousands of patients suffering from patent foramen ovale and atrial septal defect. However, no general agreement has been reached on the superiority among occluders. Thus, a meta-analysis between the two most commonly adopted types of occluders was conducted. METHODS The literature review has identified relevant studies up to May, ...

BACKGROUND Percutaneous closure of large persistent ductus arteriosus using the Amplatzer duct occluder is an alternative to surgery. However, this device is not recommended in infants weighing less than 6 kg. AIM To evaluate the safety and effectiveness of this procedure in low-body-weight infants. METHODS We reviewed retrospectively data for infants weighing less or equal to 6 kg who unde...

BACKGROUND Amplatzer occluder and Cardio-O-fix occluder are currently used in percutaneous closure of patent foramen ovale. However, there is still a lack of relevant reports comparison the differences between them. The aim of this study was to evaluate the short-term and mid-term safety and efficacy of the Cardi-O-fix occluder in preventing recurrent cerebrovascular events in patients with a p...